JMML

Clinical trials for JMML explained in plain language.

Never miss a new study

Get alerted when new JMML trials appear

Sign up with your email to follow new studies for JMML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with rare leukemia as experimental treatment begins testing

Disease control Recruiting now

This study is testing whether combining two drugs, trametinib and azacitidine, is safe and effective for children with juvenile myelomonocytic leukemia (JMML), a rare and aggressive blood cancer. Children with lower-risk JMML will receive just the two drugs, while those with high…

Matched conditions: JMML

Phase: PHASE1, PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control

Last updated Apr 17, 2026 16:11 UTC

JMML

Get alerted when new JMML trials appear

New hope for kids with rare leukemia as experimental treatment begins testing